2.24
+0.17(+8.21%)
Currency In USD
| Previous Close | 2.07 |
| Open | 2.07 |
| Day High | 2.26 |
| Day Low | 2.04 |
| 52-Week High | 3.54 |
| 52-Week Low | 0.66 |
| Volume | 1.45M |
| Average Volume | 2.21M |
| Market Cap | 208.6M |
| PE | -1.28 |
| EPS | -1.75 |
| Moving Average 50 Days | 2.22 |
| Moving Average 200 Days | 1.53 |
| Change | 0.17 |
If you invested $1000 in Caribou Biosciences, Inc. (CRBU) since IPO date, it would be worth $125.92 as of November 11, 2025 at a share price of $2.055. Whereas If you bought $1000 worth of Caribou Biosciences, Inc. (CRBU) shares 3 years ago, it would be worth $197.98 as of November 11, 2025 at a share price of $2.055.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
GlobeNewswire Inc.
Nov 03, 2025 12:00 PM GMT
Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with longer-term follow-up on patients who received optimized vis
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
GlobeNewswire Inc.
Nov 03, 2025 12:00 PM GMT
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma450 million cell dose is the recommended dose for expansion (RDE); dose expansion to initia
Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma
GlobeNewswire Inc.
Nov 02, 2025 9:00 PM GMT
BERKELEY, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that it will hold a webcast beginning at 8:00 am ET on Monday, N